These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5837313)

  • 1. Potentiation of barbital hypnosis as an evaluation method for central nervous system depressants.
    Fujimori H
    Psychopharmacologia; 1965 Apr; 7(5):374-8. PubMed ID: 5837313
    [No Abstract]   [Full Text] [Related]  

  • 2. Barbital alteration of central nervous system sensitivity to hexobarbital in the rat.
    Schnell RC; Stoll RE; Prosser TD
    Psychopharmacology (Berl); 1976 May; 47(1):93-6. PubMed ID: 959468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of barbital sodium hypnosis as a screening method for central nervous system depressants.
    Sethy VH; Mandrekar SS; Sheth UK
    Indian J Med Sci; 1967 Jan; 21(1):32-7. PubMed ID: 6035617
    [No Abstract]   [Full Text] [Related]  

  • 4. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol].
    Avakumov VM; Batulin IuM
    Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126
    [No Abstract]   [Full Text] [Related]  

  • 5. Potencies of barbiturates in mice selectively bred for resistance or susceptibility to nitrous oxide anesthesia.
    Koblin DD; Lurz FW; O'Connor B; Nelson NT; Eger EI; Bainton CR
    Anesth Analg; 1984 Jan; 63(1):35-9. PubMed ID: 6691562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to hexobarbital and supersensitivity to pilocarpine after chronic barbital treatments in the rat.
    Wahlstrŏm G; Ekwall T
    Eur J Pharmacol; 1976 Jul; 38(1):123-9. PubMed ID: 954821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The central effects of 2 groups of newly synthesized barbiturates].
    Getova D
    Eksp Med Morfol; 1988; 27(2):17-24. PubMed ID: 3168904
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction between atropine and the steric isomers of hexobarbital in normal rats and rats made tolerant to barbital.
    Wahlström G
    Eur J Pharmacol; 1979 Nov; 59(3-4):219-25. PubMed ID: 527647
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cobra venom and venom fractions on barbital-induced hypnosis in mice.
    Lal H; Sumyk G; Shefner A
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):452-60. PubMed ID: 5916747
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and basic pharmacology of N-substituted and N,N'-disubstituted ALLYL BARBITURATES.
    Weinswig MH; Burkman AM; Jones WD; Rowe EJ
    J Pharm Sci; 1967 Jul; 56(7):909-11. PubMed ID: 6034839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigations on the mechanism of enzyme induction in rats and mice. IV. Influence of age on 1-ascorbic acid excretion and its increase as well as on hexobarbital sleep duration and its reduction by barbital].
    Klinger W; Kramer B
    Acta Biol Med Ger; 1965; 15(6):707-11. PubMed ID: 5884598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of restraint on the activity, penetration and metabolism of hexobarbital and barbital in white rats].
    Buchel L; Prioux-Guyonneau M; Liblau L; Murawsky M
    Therapie; 1972; 27(4):609-25. PubMed ID: 4673389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigations on the mechanism of enzyme induction in rats and mice. V. Influence of the gonads on 1-ascorbic acid normal excretion and its increase as well as on hexobarbital sleep duration and its reduction by barbital].
    Klinger W; Koch M; Kramer B
    Acta Biol Med Ger; 1965; 15(6):700-6. PubMed ID: 5884597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of enzyme induction in rats and mice. VII. The effect of the thyroid gland on normal ascorbic acid excretion and its increase as well as on hexobarbital sleeping time and its reduction by barbital].
    Klinger W
    Acta Biol Med Ger; 1966; 16(4):404-14. PubMed ID: 5985957
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the potencies of a series of barbiturates at the neuromuscular junction and on the central nervous system.
    Lee-Son S; Waud BE; Waud DR
    J Pharmacol Exp Ther; 1975 Nov; 195(2):251-6. PubMed ID: 1185595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of some neurotropic preparations on tubular secretion].
    Fomenko GF
    Farmakol Toksikol; 1968; 31(1):67-9. PubMed ID: 5675352
    [No Abstract]   [Full Text] [Related]  

  • 17. Analgesia in rats as a result of administration of barbiturates, and its relation to hypnosis.
    HART ER; WEAVER OM
    Fed Proc; 1947; 6(1):336. PubMed ID: 20343700
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of hydralazine with barbiturates.
    Czyzewska-Szafran H; Wutkiewicz M
    Pol J Pharmacol Pharm; 1977; 29(4):347-57. PubMed ID: 905202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potentiation of hexobarbital action as a method for experimental research on substances with depressive central activity].
    Carminati GM; Chiabotto L; Duzzi L
    Boll Chim Farm; 1972 May; 111(5):293-308. PubMed ID: 4403241
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.